Table 2.
Ref. | Patients | Total number | PHG | Mild | Severe |
Sacchetti et al[24] | Cirrhosis | 142 | 38 (27%) | 28 (20%) | 10 (7%) |
D'Amico et al[25] | Cirrhosis | 212 | 130 (61%) | 110 (52%) | 20 (9%) |
Calès et al[26] | Cirrhosis | 100 | 98 (98%) | 57 (57%) | 41 (41%) |
Rabinovitz et al[27] | Cirrhosis | 510 | (43%) | Not reported | Not reported |
Iwao et al[28] | Cirrhosis | 47 | 32 (68%) | 15 (32%) | 17 (36%) |
Taranto et al[29] | Cirrhosis | 394 | 317 (80.5%) | Not reported | Not reported |
Gupta et al[30] | Cirrhosis | 230 | (61%) | (52%) | (9%) |
Iwao et al[31] | Cirrhosis | 476 | 254 (53%) | 208 (43%) | 46 (9%) |
Carpinelli et al[32] | Cirrhosis | 566 | 362 (64%) | 192 (34%) | 170 (30%) |
Zaman et al[33] | Cirrhosis | 120 | 74 (62%) | 47 (39%) | 27 (23%) |
Primignani et al[34] | Cirrhosis | 373 | 299 (80%) | 127 (34%) | 172 (46%) |
Chaves et al[35] | Cirrhosis vs schistosomiasis | 43 | 18 (81%) vs 7 (33%) | Not reported | Not reported |
Merkel et al[36] | Cirrhosis | 62 | 49 (79%) | 29 (46%) | 20 (32%) |
Merli et al[37] | Cirrhosis, with mild portal hypertension | 222 | 48 (21%) | 43 (19%) | 5 (2%) |
Ito et al[38] | Cirrhosis | 47 | 13 (27%) | 10 (21%) | 3 (6%) |
De Palma et al[39] | Cirrhosis | 37 | 23 (62%) | Not reported | Not reported |
Menchén et al[40] | Cirrhosis | 549 | 353 (64%) | 275 (50%) | 77 (14%) |
Yüksel et al[41] | Cirrhosis | 114 total | 76 (66%) | 38 (33%) | 38 (33%) |
Fontana et al[42] | Cirrhosis or bridging fibrosis from hepatitis C | 1016 | 374 (37%) | 345 (34%) | 29 (3%) |
Bresci et al[43] | Cirrhosis | 85 | 36 (42%) | Not reported | Not reported |
Akatsu et al[44] | End stage liver disease | 29 | 19 (65.5%) | 18 (62.1%) | 1 (3.4%) |
Zardi et al[45] | Cirrhosis | 266 | 84 (31%) | Not reported | Not reported |
Barakat et al[46] | Cirrhosis with portal hypertensive duodenopathy | 105 | 105 (100%) | 17 (16.2%) | 88 (83.8%) |
Bellis et al[47] | Cirrhosis | 59 | 44 (76%) | 16 (27%) | 28 (47%) |
Gravante et al[48] | Liver transplant candidates with cirrhosis | 80 | 41 (51.2%) | Not reported | Not reported |
Canlas et al[49] | Cirrhosis | 19 | 13 (68.4%) | Not reported | Not reported |
Kim et al[50] | Cirrhosis | 83 | 48 (57.8%) | Not reported | Not reported |
Higaki et al[51] | Cirrhosis | 21 | 8 (38%) | Not reported | Not reported |
Frenette et al[52] | Cirrhosis | 50 | 45 (90%) | 28 (56%) | 17 (34%) moderate |
Tarantino et al[53] | Cirrhosis | 153 | 88 (57.5%) | Not reported | Not reported |
Curvêlo et al[54] | Cirrhosis | 46 | 43 (93.4%) | 21 (45%) | 22 (47%) |
Anegawa et al[55] | Cirrhosis | 70 | 49 (70%) | 32 (46%) | 17 (24%) |
Kumar et al[56] | Cirrhosis | 254 | 140 (55%) | Not reported | Not reported |
Kim et al[57] | Cirrhosis | 331 | 298 (90%) | Mild 84 (25.4%) | 214 (64.7%) |
De Lisi et al[58] | Cirrhosis | 611 | 448 (73.3%) | 37.3% | 36% |
Abbasi et al[59] | Cirrhosis | 102 | 87 (85%) | Not reported | Not reported |
Ahmed et al[60] | Cirrhosis from hepatitis B or hepatitis C | 360 | 300 (83%) | 229 (64%) | 71 (20%) |
Garcia-Saenz-de-Sicilia et al[61] | Cirrhosis | 105 | 72 (68.6%) | Not reported | Not reported |
Abbasi et al[62] | Cirrhosis | 217 | 172 (79.3%) | 56 (25.8%) | 116 (53.5%) |
Aoyama et al[63] | Cirrhosis | 60 | 13 (22%) | Not reported | Not reported |
Laleman et al[64] | Cirrhosis with refractory chronic hepatic encephalopathy | 36 | 13 (36%) | 9 (25%) | 4 (11%) |
Giannini et al[65] | Cirrhosis and undergoing surgery for hepatocellular carcinoma | 152 | 23 (15.1%) | Not reported | Not reported |
Abdollahi et al[21] | Autoimmune hepatitis | 60 | 27 (45%) | Not reported | Not reported |
Aoyama et al[23] | Portal hypertension | 119 | 35 (29%) | Not reported | Not reported |
Aoyama et al[66] | Cirrhosis | 134 | 42 (31%) | Not reported | Not reported |
Zardi et al[67] | Cirrhosis without gastroesophageal varices | 145 | 75 (51%) | 45 (31%) | 30 (20%) |
Wu et al[68] | Cirrhosis | 700 | 449 (64%) | Mild 208 (29.7), moderate 160 (22.9%) | Severe 81 (11.6%) |
PHG: Portal hypertensive gastropathy.